Ketone body metabolism and cardiovascular disease

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 304, Issue 8, 2013, Pages

  Cotter, David G ^a   Schugar, Rebecca C ^a   Crawford, Peter A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CoA transferase SCOT; HMGCS2; Lipogenesis; Mitochondrial function; Substrate competition

Indexed keywords

COENZYME A TRANSFERASE; KETONE BODY; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE;

BIOENERGY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CATABOLISM; CITRIC ACID CYCLE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCONEOGENESIS; HEART ATRIUM FIBRILLATION; HUMAN; KETOACIDOSIS; KETOGENESIS; KETOGENIC DIET; LIVER MITOCHONDRION; MACROPHAGE; MICROFLORA; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PALMITOYLATION; PRIORITY JOURNAL; REVIEW; SUDDEN INFANT DEATH SYNDROME; ANIMAL; HEART MITOCHONDRION; HEART MUSCLE; LIPOGENESIS; LIVER; METABOLISM; OBESITY; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; COENZYME A-TRANSFERASES; FATTY ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA SYNTHASE; KETONE BODIES; LIPOGENESIS; LIVER; MITOCHONDRIA, HEART; MITOCHONDRIA, LIVER; MYOCARDIUM; OBESITY; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 84878466943     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00646.2012     Document Type: Review

References (244)

1. Abel ED, Doenst T. Mitochondrial adaptations to physiological versus pathological cardiac hypertrophy. Cardiovasc Res 90: 230-242, 2011.
2. Aguilo F, Camarero N, Relat J, Marrero PF, Haro D. Transcriptional regulation of the human acetoacetyl-CoA synthetase gene by PPARgamma. Biochem J 427: 255-264, 2010.
3. Ahmed K, Tunaru S, Offermanns S. GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends Pharmacol Sci 30: 557-562, 2009.
4. Al-Zaid NS, Dashti HM, Mathew TC, Juggi JS. Low carbohydrate ketogenic diet enhances cardiac tolerance to global ischaemia. Acta Cardiol 62: 381-389, 2007.
5. Aledo R, Zschocke J, Pie J, Mir C, Fiesel S, Mayatepek E, Hoffmann GF, Casals N, Hegardt FG. Genetic basis of mitochondrial HMG-CoA synthase deficiency. Hum Genet 109: 19-23, 2001.
6. +)-3-hydroxybutyrate in Sinorhizobium meliloti. J Bacteriol 184: 1571-1577, 2002.
7. Arias GM, Asins G, Hegardt FG, Serra D. The effect of fasting and insulin treatment on carnitine palmitoyl transferase I and mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase mRNA levels in liver from suckling rats. Biochem Soc Trans 3: 493S, 1995.
8. Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation 116: 434-448, 2007.
9. Avogaro A, Doria A, Gnudi L, Carraro A, Duner E, Brocco E, Tiengo A, Crepaldi G, Bier DM, Nosadini R. Forearm ketone body metabolism in normal and in insulin-dependent diabetic patients. Am J Physiol Endocrinol Metab 263: E261-E267, 1992.
10. Ayté J, Gil-Gómez G, Hegardt FG. Methylation of the regulatory region of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene leads to its transcriptional inactivation. Biochem J 295: 807-812, 1993.
11. Backhed F, Crawford PA. Coordinated regulation of the metabolome and lipidome at the host-microbial interface. Biochim Biophys Acta 1801: 240-245, 2010.
12. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101: 15718-15723, 2004.
13. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104: 979-984, 2007.
14. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5: 426-437, 2007.
15. Balasse EO, Fery F. Ketone body production and disposal: effects of fasting, diabetes, and exercise. Diabetes Metab Rev 5: 247-270, 1989.
16. Bergman BC, Cornier MA, Horton TJ, Bessesen DH. Effects of fasting on insulin action and glucose kinetics in lean and obese men and women. Am J Physiol Endocrinol Metab 293: E1103-E1111, 2007.
17. Bergstrom JD, Wong GA, Edwards PA, Edmond J. The regulation of acetoacetyl-CoA synthetase activity by modulators of cholesterol synthesis in vivo and the utilization of acetoacetate for cholesterogenesis. J Biol Chem 259: 14548-14553, 1984.
18. Berry GT, Fukao T, Mitchell GA, Mazur A, Ciafre M, Gibson J, Kondo N, Palmieri MJ. Neonatal hypoglycaemia in severe succinyl-CoA: 3-oxoacid CoA-transferase deficiency. J Inherit Metab Dis 24: 587-595, 2001.
19. Bickerton AS, Roberts R, Fielding BA, Tornqvist H, Blaak EE, Wagenmakers AJ, Gilbert M, Humphreys SM, Karpe F, Frayn KN. Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia 51: 1466-1474, 2008.
20. Bing RJ. The metabolism of the heart. Harvey Lect 50: 27-70, 1955.
21. Bisschop PH, de Metz J, Ackermans MT, Endert E, Pijl H, Kuipers F, Meijer AJ, Sauerwein HP, Romijn JA. Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 73: 554-559, 2001.
22. Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K. Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab 283: E20-E28, 2002.
23. Blumberg R, Powrie F. Microbiota, disease, and back to health: a metastable journey. Sci Transl Med 4: 137rv137, 2012.
24. Bock H, Fleischer S. Preparation of a homogeneous soluble D-betahydroxybutyrate apodehydrogenase from mitochondria. J Biol Chem 250: 5774-5761, 1975.
25. Bodamer OA, Hussein K, Morris AA, Langhans CD, Rating D, Mayatepek E, Leonard JV. Glucose and leucine kinetics in idiopathic ketotic hypoglycaemia. Arch Dis Child 91: 483-486, 2006.
26. Bouchard L, Robert MF, Vinarov D, Stanley CA, Thompson GN, Morris A, Leonard JV, Quant P, Hsu BY, Boneh A, Boukaftane Y, Ashmarina L, Wang S, Miziorko H, Mitchell GA. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: clinical course and description of causal mutations in two patients. Pediatr Res 49: 326-331, 2001.
27. Boudina S, Abel ED. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11: 31-39, 2010.
28. Boukaftane Y, Duncan A, Wang S, Labuda D, Robert MF, Sarrazin J, Schappert K, Mitchell GA. Human mitochondrial HMG CoA synthase: liver cDNA and partial genomic cloning, chromosome mapping to 1p12-p13, and possible role in vertebrate evolution. Genomics 23: 552-559, 1994.
29. Bregere C, Rebrin I, Gallaher TK, Sohal RS. Effects of age and calorie restriction on tryptophan nitration, protein content, and activity of succinyl-CoA:3-ketoacid CoA transferase in rat kidney mitochondria. Free Radic Biol Med 48: 609-618, 2010.
30. Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess SC. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr 93: 1048-1052, 2011.
31. Cahill GF Jr. Fuel metabolism in starvation. Annu Rev Nutr 26: 1-22, 2006.
32. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T, Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772, 2007.
33. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481, 2008.
34. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck AM, Lambert DM, Muccioli GG, Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 57: 1091-1103, 2009.
35. Clarke K, Tchabanenko K, Pawlosky R, Carter E, Todd King M, Musa-Veloso K, Ho M, Roberts A, Robertson J, Vanitallie TB, Veech RL. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol 63: 401-408, 2012.
36. Claus SP, Tsang TM, Wang Y, Cloarec O, Skordi E, Martin FP, Rezzi S, Ross A, Kochhar S, Holmes E, Nicholson JK. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol 4: 219, 2008.
37. Cooper RH, Randle PJ, Denton RM. Stimulation of phosphorylation and inactivation of pyruvate dehydrogenase by physiological inhibitors of the pyruvate dehydrogenase reaction. Nature 257: 808-809, 1975.
38. Cotter DG, d'Avignon DA, Wentz AE, Weber ML, Crawford PA. Obligate role for ketone body oxidation in neonatal metabolic homeostasis. J Biol Chem 286: 6902-6910, 2011.
39. Cotter DG, Schugar RC, Wentz AE, d'Avignon DA, Crawford PA. Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation. Am J Physiol Endocrinol Metab 304: E363-E374, 2013.
40. Crawford PA, Crowley JR, Sambandam N, Muegge BD, Costello EK, Hamady M, Knight R, Gordon JI. Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc Natl Acad Sci USA 106: 11276-11281, 2009.
41. Cunnane SC, Crawford MA. Survival of the fattest: fat babies were the key to evolution of the large human brain. Comp Biochem Physiol A Mol Integr Physiol 136: 17-26, 2003.
42. Des Rosiers C, Labarthe F, Lloyd SG, Chatham JC. Cardiac anaplerosis in health and disease: food for thought. Cardiovasc Res 90: 210-219, 2011.
43. Des Rosiers C, Montgomery JA, Garneau M, David F, Mamer OA, Daloze P, Toffolo G, Cobelli C, Landau BR, Brunengraber H. Pseudoketogenesis in hepatectomized dogs. Am J Physiol Endocrinol Metab 258: E519-E528, 1990.
44. + outward current in myocardial mouse cells in a stereoselective fashion. J Physiol 500: 85-94, 1997.
45. Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang H, Kim J, Woo J, Kim JH, Choi BH, He B, Chen W, Zhang S, Cerione RA, Auwerx J, Hao Q, Lin H. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334: 806-809, 2011.
46. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon JC, Mitchell SC, Holmes E, McCarthy MI, Scott J, Gauguier D, Nicholson JK. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103: 12511-12516, 2006.
47. Edmond J. Ketone bodies as precursors of sterols and fatty acids in the developing rat. J Biol Chem 249: 72-80, 1974.
48. Edmond J, Robbins RA, Bergstrom JD, Cole RA, de Vellis J. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res 18: 551-561, 1987.
49. Endemann G, Goetz PG, Edmond J, Brunengraber H. Lipogenesis from ketone bodies in the isolated perfused rat liver. Evidence for the cytosolic activation of acetoacetate. J Biol Chem 257: 3434-3440, 1982.
50. Fellman V, Kotarsky H. Mitochondrial hepatopathies in the newborn period. Semin Fetal Neonatal Med 16: 222-228, 2011.
51. Fenselau A, Wallis K. 3-Oxo acid coenzyme A-transferase in normal and diabetic rat muscle. Biochem J 158: 509-512, 1976.
52. Fenselau A, Wallis K. Substrate specificity and mechanism of action of acetoacetate coenzyme A transferase from rat heart. Biochemistry 13: 3884-3888, 1974.
53. Ferre P, Satabin P, Decaux J, Escriva F, Girard J. Development and regulation of ketogenesis in hepatocytes isolated from newborn rats. Biochem J 214: 937-942, 1983.
54. Fery F, Balasse EO. Ketone body production and disposal in diabetic ketosis. A comparison with fasting ketosis. Diabetes 34: 326-332, 1985.
55. Fink G, Desrochers S, Des Rosiers C, Garneau M, David F, Daloze T, Landau BR, Brunengraber H. Pseudoketogenesis in the perfused rat heart. J Biol Chem 263: 18036-18042, 1988.
56. Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL, Brill C, Stein RI, Mohammed BS, Miller B, Rader DJ, Zemel B, Wadden TA, Tenhave T, Newcomb CW, Klein S. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med 153: 147-157, 2010.
57. Freed LE, Endemann G, Tomera JF, Gavino VC, Brunengraber H. Lipogenesis from ketone bodies in perfused livers from streptozocininduced diabetic rats. Diabetes 37: 50-55, 1988.
58. Fukao T. 3-ketoacid CoA transferase (SCOT) deficiency. Orphanet encyclopedia, 2001 (www.orpha.net).
59. Fukao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 70: 243-251, 2004.
60. Fukao T, Mitchell GA, Song XQ, Nakamura H, Kassovska-Bratinova S, Orii KE, Wraith JE, Besley G, Wanders RJ, Niezen-Koning KE, Berry GT, Palmieri M, Kondo N. Succinyl-CoA:3-ketoacid CoA transferase (SCOT): cloning of the human SCOT gene, tertiary structural modeling of the human SCOT monomer, and characterization of three pathogenic mutations. Genomics 68: 144-151, 2000.
61. Fukao T, Sakurai S, Rolland MO, Zabot MT, Schulze A, Yamada K, Kondo N. A 6-bp deletion at the splice donor site of the first intron resulted in aberrant splicing using a cryptic splice site within exon 1 in a patient with succinyl-CoA: 3-Ketoacid CoA transferase (SCOT) deficiency. Mol Genet Metab 89: 280-282, 2006.
62. Fukao T, Song XQ, Mitchell GA, Yamaguchi S, Sukegawa K, Orii T, Kondo N. Enzymes of ketone body utilization in human tissues: protein and messenger RNA levels of succinyl-coenzyme A (CoA):3-ketoacid CoA transferase and mitochondrial and cytosolic acetoacetyl-CoA thiolases. Pediatr Res 42: 498-502, 1997.
63. Garland PB, Newsholme EA, Randle PJ. Effect of fatty acids, ketone bodies, diabetes and starvation on pyruvate metabolism in rat heart and diaphragm muscle. Nature 195: 381-383, 1962.
64. Garland PB, Randle PJ, Newsholme EA. Citrate as an intermediary in the inhibition of phosphofructokinase in rat heart muscle by fatty acids, ketone bodies, pyruvate, diabetes, and starvation. Nature 200: 169-170, 1963.
65. Geelen MJ, Lopes-Cardozo M, Edmond J. Acetoacetate: a major substrate for the synthesis of cholesterol and fatty acids by isolated rat hepatocytes. FEBS Lett 163: 269-273, 1983.
66. Girard J, Ferre P, Pegorier JP, Duee PH. Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol Rev 72: 507-562, 1992.
67. Gordon JI. Honor thy gut symbionts redux. Science 336: 1251-1253, 2012.
68. Grimsrud PA, Carson JJ, Hebert AS, Hubler SL, Niemi NM, Bailey DJ, Jochem A, Stapleton DS, Keller MP, Westphall MS, Yandell BS, Attie AD, Coon JJ, Pagliarini DJ. A quantitative map of the liver mitochondrial phosphoproteome reveals posttranslational control of ketogenesis. Cell Metab 16: 672-683, 2012.
69. Grinblat L, Pacheco Bolanos LF, Stoppani AO. Decreased rate of ketone-body oxidation and decreased activity of D-3-hydroxybutyrate dehydrogenase and succinyl-CoA:3-oxo-acid CoA-transferase in heart mitochondria of diabetic rats. Biochem J 240: 49-56, 1986.
70. Guo K, Lukacik P, Papagrigoriou E, Meier M, Lee WH, Adamski J, Oppermann U. Characterization of human DHRS6, an orphan short chain dehydrogenase/reductase enzyme: a novel, cytosolic type 2 R-betahydroxybutyrate dehydrogenase. J Biol Chem 281: 10291-10297, 2006.
71. Haas JT, Miao J, Chanda D, Wang Y, Zhao E, Haas ME, Hirschey M, Vaitheesvaran B, Farese RV Jr, Kurland IJ, Graham M, Crooke R, Foufelle F, Biddinger SB. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feedingdependent expression. Cell Metab 15: 873-884, 2012.
72. Haces ML, Hernandez-Fonseca K, Medina-Campos ON, Montiel T, Pedraza-Chaverri J, Massieu L. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp Neurol 211: 85-96, 2008.
73. Halestrap AP. The monocarboxylate transporter family-Structure and functional characterization. IUBMB Life 64: 1-9, 2012.
74. Halestrap AP, Wilson MC. The monocarboxylate transporter family-role and regulation. IUBMB Life 64: 109-119, 2012.
75. Hall SE, Wastney ME, Bolton TM, Braaten JT, Berman M. Ketone body kinetics in humans: the effects of insulin-dependent diabetes, obesity, and starvation. J Lipid Res 25: 1184-1194, 1984.
76. Hasan NM, Longacre MJ, Seed-Ahmed M, Kendrick MA, Gu H, Ostenson CG, Fukao T, Macdonald MJ. Lower succinyl-CoA:3-ketoacid-CoA transferase (SCOT) and ATP citrate lyase in pancreatic islets of a rat model of type 2 diabetes: knockdown of SCOT inhibits insulin release in rat insulinoma cells. Arch Biochem Biophys 499: 62-68, 2010.
77. Hasegawa S, Ikeda Y, Yamasaki M, Fukui T. The role of acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, in 3T3-L1 adipocyte differentiation. Biol Pharm Bull 35: 1980-1985, 2012.
78. Hasegawa S, Kume H, Iinuma S, Yamasaki M, Takahashi N, Fukui T. Acetoacetyl-CoA synthetase is essential for normal neuronal development. Biochem Biophys Res Commun 427: 398-403, 2012.
79. Hasegawa S, Noda K, Maeda A, Matsuoka M, Yamasaki M, Fukui T. Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels. Mol Genet Metab 107: 553-560, 2012.
80. Hasselbaink DM, Glatz JF, Luiken JJ, Roemen TH, Van der Vusse GJ. Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats. Biochem J 371: 753-760, 2003.
81. Hawdon J. Hypoglycaemia and the neonatal brain. Eur J Pediatr 158: S9-S12, 1999.
82. Hegardt FG. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem J 338: 569-582, 1999.
83. Holmes E, Kinross J, Gibson GR, Burcelin R, Jia W, Pettersson S, Nicholson JK. Therapeutic modulation of microbiota-host metabolic interactions. Sci Transl Med 4: 137rv136, 2012.
84. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA, Daviglus ML, Kesteloot H, Ueshima H, Zhao L, Nicholson JK, Elliott P. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453: 396-400, 2008.
85. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 336: 1268-1273, 2012.
86. Hoverstad T, Midtvedt T. Short-chain fatty acids in germfree mice and rats. J Nutr 116: 1772-1776, 1986.
87. Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 297: E578-E591, 2009.
88. Huelsmann WC, Siliprandi D, Ciman M, Siliprandi N. Effect of carnitine on the oxidation of alpha-oxoglutarate to succinate in the presence of acetoacetate or pyruvate. Biochim Biophys Acta 93: 166-168, 1964.
89. Hugo SE, Cruz-Garcia L, Karanth S, Anderson RM, Stainier DY, Schlegel A. A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev 26: 282-293, 2012.
90. Huidekoper HH, Duran M, Turkenburg M, Ackermans MT, Sauerwein HP, Wijburg FA. Fasting adaptation in idiopathic ketotic hypoglycemia: a mismatch between glucose production and demand. Eur J Pediatr 167: 859-865, 2008.
91. Human Microbiome Project Consortium. A framework for human microbiome research. Nature 486: 215-221, 2012.
92. Human Microbiome Project Consortium. Structure function, and diversity of the healthy human microbiome. Nature 486: 207-214, 2012.
93. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ, Kliewer SA. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 5: 415-425, 2007.
94. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95: 135-145, 2004.
95. Ito M, Fukui T, Kamokari M, Saito T, Tomita K. Purification and characterization of acetoacetyl-CoA synthetase from rat liver. Biochim Biophys Acta 794: 183-193, 1984.
96. Janardhan A, Chen J, Crawford PA. Altered systemic ketone body metabolism in advanced heart failure. Tex Heart Inst J 38: 533-538, 2011.
97. Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD. Targeting fatty acid and carbohydrate oxidation-a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta 1813: 1333-1350, 2011.
98. Jeffrey FM, Diczku V, Sherry AD, Malloy CR. Substrate selection in the isolated working rat heart: effects of reperfusion, afterload, and concentration. Basic Res Cardiol 90: 388-396, 1995.
99. Jeoung NH, Rahimi Y, Wu P, Lee WN, Harris RA. Fasting induces ketoacidosis and hypothermia in PDHK2/PDHK4-double-knockout mice. Biochem J 443: 829-839, 2012.
100. Johnson RH, Walton JL, Krebs HA, Williamson DH. Post-exercise ketosis. Lancet 2: 1383-1385, 1969.
101. Jones JG, Hansen J, Sherry AD, Malloy CR, Victor RG. Determination of acetyl-CoA enrichment in rat heart and skeletal muscle by 1H nuclear magnetic resonance analysis of glutamate in tissue extracts. Analytical biochemistry 249: 201-206, 1997.
102. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25, 2005.
103. Kashiwaya Y, Pawlosky R, Markis W, King MT, Bergman C, Srivastava S, Murray A, Clarke K, Veech RL. A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat. J Biol Chem 285: 25950-25956, 2010.
104. Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL, Passonneau JV. Control of glucose utilization in working perfused rat heart. J Biol Chem 269: 25502-25514, 1994.
105. Kassovska-Bratinova S, Fukao T, Song XQ, Duncan AM, Chen HS, Robert MF, Perez-Cerda C, Ugarte M, Chartrand C, Vobecky S, Kondo N, Mitchell GA. Succinyl CoA: 3-oxoacid CoA transferase (SCOT): human cDNA cloning, human chromosomal mapping to 5p13, and mutation detection in a SCOT-deficient patient. Am J Hum Genet 59: 519-528, 1996.
106. Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S, Kobayashi M, Hirasawa A, Tsujimoto G. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G proteincoupled receptor 41 (GPR41). Proc Natl Acad Sci USA 108: 8030-8035, 2011.
107. Kinman RP, Kasumov T, Jobbins KA, Thomas KR, Adams JE, Brunengraber LN, Kutz G, Brewer WU, Roe CR, Brunengraber H. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. Am J Physiol Endocrinol Metab 291: E860-E866, 2006.
108. Kochar IS, Hussain K. From hyperinsulinaemic hypoglycaemia to ketotic hypoglycaemia: the range of glucose abnormalities in patients born with intrauterine growth retardation. Eur J Pediatr 166: 1003-1007, 2007.
109. Kolwicz SC Jr, Tian R. Glucose metabolism and cardiac hypertrophy. Cardiovasc Res 90: 194-201, 2011.
110. Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism based therapies. Curr Opin Neurol 25: 173-178, 2012.
111. Kostiuk MA, Keller BO, Berthiaume LG. Palmitoylation of ketogenic enzyme HMGCS2 enhances its interaction with PPARα and transcription at the Hmgcs2 PPRE. FASEB J 24: 1914-1924, 2010.
112. Krebs P, Fan W, Chen YH, Tobita K, Downes MR, Wood MR, Sun L, Li X, Xia Y, Ding N, Spaeth JM, Moresco EM, Boyer TG, Lo CW, Yen J, Evans RM, Beutler B. Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet. Proc Natl Acad Sci USA 108: 19678-19682, 2011.
113. Krishnakumar AM, Sliwa D, Endrizzi JA, Boyd ES, Ensign SA, Peters JW. Getting a handle on the role of coenzyme M in alkene metabolism. Microbiol Mol Biol Rev 72: 445-456, 2008.
114. Kuhara T, Inoue Y, Shinka T, Matsumoto I, Matsuo M. Identification of 3-hydroxy-3-ethylglutaric acid in urine of patients with propionic acidaemia. Biomed Mass Spectrom 10: 629-632, 1983.
115. Kupari M, Lommi J, Ventila M, Karjalainen U. Breath acetone in congestive heart failure. Am J Cardiol 76: 1076-1078, 1995.
116. Kwiterovich PO Jr, Vining EP, Pyzik P, Skolasky R Jr, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 290: 912-920, 2003.
117. Labarthe F, Gélinas R, Des Rosiers C. Medium-chain fatty acids as metabolic therapy in cardiac disease. Cardiovasc Drugs Ther 22: 97-106, 2008.
118. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, Gatling W, Bingley PJ, Patterson CC. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46: 760-765, 2003.
119. Lehninger ALSH, Wise JB. D-β-Hydroxybutyric dehydrogenase of mitochondria. J Biol Chem 235: 2450-2455, 1960.
120. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102: 11070-11075, 2005.
121. Li JV, Ashrafian H, Bueter M, Kinross J, Sands C, le Roux CW, Bloom SR, Darzi A, Athanasiou T, Marchesi JR, Nicholson JK, Holmes E. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60: 1214-1223, 2011.
122. Lincoln BC, Des Rosiers C, Brunengraber H. Metabolism of S-3-hydroxybutyrate in the perfused rat liver. Arch Biochem Biophys 259: 149-156, 1987.
123. Lodhi IJ, Yin L, Jensen-Urstad AP, Funai K, Coleman T, Baird JH, El Ramahi MK, Razani B, Song H, Fu-Hsu F, Turk J, Semenkovich CF. Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARgamma activation to decrease diet-induced obesity. Cell Metab 16: 189-201, 2012.
124. Lommi J, Koskinen P, Naveri H, Harkonen M, Kupari M. Heart failure ketosis. J Intern Med 242: 231-238, 1997.
125. Lommi J, Kupari M, Koskinen P, Naveri H, Leinonen H, Pulkki K, Harkonen M. Blood ketone bodies in congestive heart failure. J Am Coll Cardiol 28: 665-672, 1996.
126. Longo N, Fukao T, Singh R, Pasquali M, Barrios RG, Kondo N, Gibson KM. Succinyl-CoA:3-ketoacid transferase (SCOT) deficiency in a new patient homozygous for an R217X mutation. J Inherit Metab Dis 27: 691-692, 2004.
127. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 90: 207-258, 2010.
128. Lowe DM, Tubbs PK. 3-Hydroxy-3-methylglutaryl-coenzyme A synthase from ox liver. Purification, molecular and catalytic properties. Biochem J 227: 591-599, 1985.
129. Lukasova M, Malaval C, Gille A, Kero J, Offermanns S. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 121: 1163-1173, 2011.
130. Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 145: 256-264, 2007.
131. MacDonald MJ. Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells. J Biol Chem 282: 6043-6052, 2007.
132. MacDonald MJ, Hasan N, Longacre M. Studies with leucine, β-hydroxybutyrate and ATP citrate lyase-deficient beta cells support the acetoacetate pathway of insulin secretion. Biochim Biophys Acta 1780: 966-972, 2008.
133. MacDonald MJ, Longacre MJ, Stoker SW, Brown LJ, Hasan NM, Kendrick MA. Acetoacetate and beta-hydroxybutyrate in combination with other metabolites release insulin from INS-1 cells and provide clues about pathways in insulin secretion. Am J Physiol Cell Physiol 294: C442-C450, 2008.
134. Magnusson I, Schumann WC, Bartsch GE, Chandramouli V, Kumaran K, Wahren J, Landau BR. Noninvasive tracing of krebs cycle metabolism in liver. J Biol Chem 266: 6975-6984, 1991.
135. Marcondes S, Turko IV, Murad F. Nitration of succinyl-CoA:3-oxoacid CoA-transferase in rats after endotoxin administration. Proc Natl Acad Sci USA 98: 7146-7151, 2001.
136. Mayr M, Yusuf S, Weir G, Chung YL, Mayr U, Yin X, Ladroue C, Madhu B, Roberts N, De Souza A, Fredericks S, Stubbs M, Griffiths JR, Jahangiri M, Xu Q, Camm AJ. Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol 51: 585-594, 2008.
137. McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49: 395-420, 1980.
138. McGarry JD, Stark MJ, Foster DW. Hepatic malonyl-CoA levels of fed, fasted and diabetic rats as measured using a simple radioisotopic assay. J Biol Chem 253: 8291-8293, 1978.
139. McNally MA, Hartman AL. Ketone bodies in epilepsy. J Neurochem 121: 28-35, 2012.
140. Meertens LM, Miyata KS, Cechetto JD, Rachubinski RA, Capone JP. A mitochondrial ketogenic enzyme regulates its gene expression by association with the nuclear hormone receptor PPARalpha. EMBO J 17: 6972-6978, 1998.
141. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, Corthesy I, Mace K, Chou CJ. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 22: 2416-2426, 2008.
142. Merritt ME, Harrison C, Sherry AD, Malloy CR, Burgess SC. Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13C magnetic resonance. Proc Natl Acad Sci USA 108: 19084-19089, 2011.
143. Mitchell GA, Fukao T. Inborn errors of ketone body metabolism. In: The Online Metabolic and Molecular Bases of Inherited Diseases (OMMBID), edited by Beaudet A, Vogelstein B, Kinzler KW, Antonarakis S, and Ballabio A. Columbus, OH: McGraw-Hill, 2000, part 10, chapt 102, p. 12.
144. Morris AA. Cerebral ketone body metabolism. J Inherit Metab Dis 28: 109-121, 2005.
145. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 15: 289-329, 1972.
146. Newsholme P, Curi R, Gordon S, Newsholme EA. Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem J 239: 121-125, 1986.
147. Newsholme P, Gordon S, Newsholme EA. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J 242: 631-636, 1987.
148. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Science 336: 1262-1267, 2012.
149. Niezen-Koning KE, Wanders RJ, Ruiter JP, Ijlst L, Visser G, Reitsma-Bierens WC, Heymans HS, Reijngoud DJ, Smit GP. Succinyl-CoA:acetoacetate transferase deficiency: identification of a new patient with a neonatal onset and review of the literature. Eur J Pediatr 156: 870-873, 1997.
150. Niezen-Koning KE, Wanders RJ, Ruiter JP, Ijlst L, Visser G, Reitsma-Bierens WC, Heymans HS, Reijngoud DJ, Smit GP. Succinyl-CoA:acetoacetate transferase deficiency: identification of a new patient with a neonatal onset and review of the literature. Eur J Pediatr 156: 870-873, 1997.
151. Odegaard JI, Chawla A. Alternative macrophage activation and metabolism. Annu Rev Pathol Mech Dis 6: 275-297, 2011.
152. Okuda Y, Kawai K, Ohmori H, Yamashita K. Ketone body utilization and its metabolic effect in resting muscles of normal and streptozotocindiabetic rats. Endocr J 38: 245-251, 1991.
153. Orii KE, Fukao T, Song XQ, Mitchell GA, Kondo N. Liver-specific silencing of the human gene encoding succinyl-CoA: 3-ketoacid CoA transferase. Tohoku J Exp Med 215: 227-236, 2008.
154. Owen OE, Kalhan SC, Hanson RW. The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem 277: 30409-30412, 2002.
155. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J Clin Invest 46: 1589-1595, 1967.
156. Pelletier A, Tardif A, Gingras MH, Chiasson JL, Coderre L. Chronic exposure to ketone bodies impairs glucose uptake in adult cardiomyocytes in response to insulin but not vanadate: the role of PI3-K. Mol Cell Biochem 296: 97-108, 2007.
157. Phillips JW, Hird FJ. Ketogenesis in vertebrate livers. Comp Biochem Physiol B 57: 133-138, 1977.
158. Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med 271: 403-409, 1964.
159. Pryce JW, Weber MA, Heales S, Malone M, Sebire NJ. Tandem mass spectrometry findings at autopsy for detection of metabolic disease in infant deaths: postmortem changes and confounding factors. J Clin Pathol 64: 1005-1009, 2011.
160. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60, 2012.
161. Quant PA, Robin D, Robin P, Girard J, Brand MD. A top-down control analysis in isolated rat liver mitochondria: can the 3-hydroxy-3-methylglutaryl-CoA pathway be rate-controlling for ketogenesis? Biochim Biophys Acta 1156: 135-143, 1993.
162. Quant PA, Tubbs PK, Brand MD. Glucagon activates mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in vivo by decreasing the extent of succinylation of the enzyme. Eur J Biochem 187: 169-174, 1990.
163. Rebrin I, Bregere C, Kamzalov S, Gallaher TK, Sohal RS. Nitration of tryptophan 372 in succinyl-CoA:3-ketoacid CoA transferase during aging in rat heart mitochondria. Biochemistry 46: 10130-10144, 2007.
164. Reed WD, Clinkenbeard D, Lane MD. Molecular and catalytic properties of mitochondrial (ketogenic) 3-hydroxy-3-methylglutaryl coenzyme A synthase of liver. J Biol Chem 250: 3117-3123, 1975.
165. +)-3-hydroxybutyrate metabolism in the rat. Arch Biochem Biophys 205: 94-103, 1980.
166. Reichard GA Jr, Owen OE, Haff AC, Paul P, and Bortz WM. Ketone-body production and oxidation in fasting obese humans. J Clin Invest 53: 508-515, 1974.
167. Robinson AM, Williamson DH. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev 60: 143-187, 1980.
168. Robinson AM, Williamson DH. Utilization of D-3-hydroxy[3-14C]-butyrate for lipogenesis in vivo in lactating rat mammary gland. Biochem J 176: 635-638, 1978.
169. Rodriguez JC, Gil-Gomez G, Hegardt FG, Haro D. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J Biol Chem 269: 18767-18772, 1994.
170. Roe CR, Sweetman L, Roe DS, David F, Brunengraber H. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 110: 259-269, 2002.
171. Roe CR, Yang BZ, Brunengraber H, Roe DS, Wallace M, Garritson BK. Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy. Neurology 71: 260-264, 2008.
172. Rosca MG, Lemieux H, Hoppel CL. Mitochondria in the elderly: Is acetylcarnitine a rejuvenator? Adv Drug Deliv Rev 61: 1332-1342, 2009.
173. Roy M, Nugent S, Tremblay-Mercier J, Tremblay S, Courchesne-Loyer A, Beaudoin JF, Tremblay L, Descoteaux M, Lecomte R, Cunnane SC. The ketogenic diet increases brain glucose and ketone uptake in aged rats: a dual tracer PET and volumetric MRI study. Brain Res 1488: 14-23, 2012.
174. Rudolph W, Schinz A. Studies on myocardial blood flow, oxygen consumption, and myocardial metabolism in patients with cardiomyopathy. Recent Adv Stud Card Struct Metab 2: 739-749, 1973.
175. Russell RR 3rd, Taegtmeyer H. Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate. J Clin Invest 87: 384-390, 1991.
176. Russell RR 3rd, Taegtmeyer H. Coenzyme A sequestration in rat hearts oxidizing ketone bodies. J Clin Invest 89: 968-973, 1992.
177. Russell RR 3rd, Taegtmeyer H. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol Heart Circ Physiol 261: H1756-H1762, 1991.
178. Sandermann H Jr, McIntyre JO, Fleischer S. Site-site interaction in the phospholipid activation of D-beta-hydroxybutyrate dehydrogenase. J Biol Chem 261: 6201-6208, 1986.
179. Satapati S, Sunny NE, Kucejova B, Fu X, He T, Mendez-Lucas A, Shelton JM, Perales JC, Browning JD, Burgess SC. Elevated TCA cycle function in the pathology of diet induced hepatic insulin resistance and fatty liver. J Lipid Res 53: 1080-1092, 2012.
180. Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, Chance B, Clarke K, Veech RL. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J 9: 651-658, 1995.
181. Saudubray JM, Specola N, Middleton B, Lombes A, Bonnefont JP, Jakobs C, Vassault A, Charpentier C, Day R. Hyperketotic states due to inherited defects of ketolysis. Enzyme 38: 80-90, 1987.
182. Schneider JG, Yang Z, Chakravarthy MV, Lodhi IJ, Wei X, Turk J, Semenkovich CF. Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. J Biol Chem 285: 23398-23409, 2010.
183. Schuler AM, Wood PA. Mouse models for disorders of mitochondrial fatty acid beta-oxidation. ILAR J 43: 57-65, 2002.
184. +)-3-hydroxybutyrate by liver. Arch Biochem Biophys 214: 268-272, 1982.
185. Scrutton MC, Utter MF. Pyruvate carboxylase. IX. Some properties of the activation by certain acyl derivatives of coenzyme A. J Biol Chem 242: 1723-1735, 1967.
186. Sengupta S, Peterson T, Laplante M, Oh S, Sabatini D. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468: 1100-1104, 2010.
187. Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Metabolic management of brain cancer. Biochim Biophys Acta 1807: 577-594, 2011.
188. Shimazu T, Hirschey MD, Hua L, Dittenhafer-Reed KE, Schwer B, Lombard DB, Li Y, Bunkenborg J, Alt FW, Denu JM, Jacobson MP, Verdin E. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab 12: 654-661, 2010.
189. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339: 211-214, 2013.
190. Skrha J, Kunesova M, Hilgertova J, Weiserova H, Krizova J, Kotrlikova E. Short-term very low calorie diet reduces oxidative stress in obese type 2 diabetic patients. Physiol Res 54: 33-39, 2005.
191. Snorek M, Hodyc D, Sedivy V, Durisova J, Skoumalova A, Wilhelm J, Neckar J, Kolar F, Herget J. Short-term fasting reduces the extent of myocardial infarction and incidence of reperfusion arrhythmias in rats. Physiol Res 61: 567-574, 2013.
192. Snyderman SE, Sansaricq C, Middleton B. Succinyl-CoA:3-ketoacid CoA-transferase deficiency. Pediatrics 101: 709-711, 1998.
193. Soeters MR, Sauerwein HP, Faas L, Smeenge M, Duran M, Wanders RJ, Ruiter AF, Ackermans MT, Fliers E, Houten SM, Serlie MJ. Effects of insulin on ketogenesis following fasting in lean and obese men. Obesity (Silver Spring) 17: 1326-1331, 2009.
194. Srere PA, Foster DW. On the proposed relation of citrate enzymes to fatty acid synthesis and ketosis in starvation. Biochem Biophys Res Commun 26: 556-561, 1967.
195. Srivastava S, Kashiwaya Y, King MT, Baxa U, Tam J, Niu G, Chen X, Clarke K, Veech RL. Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet. FASEB J 26: 2351-2362, 2012.
196. Stanley WC, Meadows SR, Kivilo KM, Roth BA, Lopaschuk GD. β-Hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content. Am J Physiol Heart Circ Physiol 285: H1626-H1631, 2003.
197. Stern JR, Coon MJ, Del Campillo A. Enzymes of fatty acid metabolism. III. Breakdown and synthesis of beta-keto fatty acids. J Biol Chem 221: 1-14, 1956.
198. Stern JR, Coon MJ, Del Campillo A, Schneider MC. Enzymes of fatty acid metabolism. IV. Preparation and properties of coenzyme A transferase. J Biol Chem 221: 15-31, 1956.
199. Sultan AM. D-3-hydroxybutyrate metabolism in the perfused rat heart. Mol Cell Biochem 79: 113-118, 1988.
200. Sunny NE, Satapati S, Fu X, He TT, Mehdibeigi R, Spring-Robinson C, Duarte J, Potthoff MJ, Browning JD, Burgess SC. Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet. Am J Physiol Endocrinol Metab 298: E1226-E1235, 2010.
201. Suzuki J, Shen WJ, Nelson BD, Selwood SP, Murphy GM Jr, Kanehara H, Takahashi S, Oida K, Miyamori I, Kraemer FB. Cardiac gene expression profile and lipid accumulation in response to starvation. Am J Physiol Endocrinol Metab 283: E94-E102, 2002.
202. Sweetman L, Weyler W, Nyhan WL, de Cespedes C, Loria AR, Estrada Y. Abnormal metabolites of isoleucine in a patient with propionyl-CoA carboxylase deficiency. Biomed Mass Spectrom 5: 198-207, 1978.
203. Taegtmeyer H, Hems R, Krebs HA. Utilization of energy-providing substrates in the isolated working rat heart. Biochem J 186: 701-711, 1980.
204. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 105: 1727-1733, 2002.
205. Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, Ren N, Kaplan R, Wu K, Wu TJ, Jin L, Liaw C, Chen R, Richman J, Connolly D, Offermanns S, Wright SD, Waters MG. (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 280: 26649-26652, 2005.
206. Tardif A, Julien N, Pelletier A, Thibault G, Srivastava AK, Chiasson JL, Coderre L. Chronic exposure to beta-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes. Am J Physiol Endocrinol Metab 281: E1205-E1212, 2001.
207. Thomas LK, Ittmann M, Cooper C. The role of leucine in ketogenesis in starved rats. Biochem J 204: 399-403, 1982.
208. Thompson GN, Hsu BY, Pitt JJ, Treacy E, Stanley CA. Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N Engl J Med 337: 1203-1207, 1997.
209. Thumelin SF, Girard J, Pegorier JP. Developmental changes in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression in rat liver, intestine and kidney. Biochem J 292: 493-496, 1993.
210. Tildon JT, Cornblath M. Succinyl-CoA: 3-ketoacid CoA-transferase deficiency. A cause for ketoacidosis in infancy. J Clin Invest 51: 493-498, 1972.
211. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249, 2012.
212. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, Offermanns S. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9: 352-355, 2003.
213. Turko IV, Marcondes S, Murad F. Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol 281: H2289-H2294, 2001.
214. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3: 213-223, 2008.
215. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031, 2006.
216. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1: 6ra14, 2009.
217. Valera A, Pelegrin M, Asins G, Fillat C, Sabater J, Pujol A, Hegardt FG, Bosch F. Overexpression of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in transgenic mice causes hepatic hyperketogenesis. J Biol Chem 269: 6267-6270, 1994.
218. Vanoverschelde JL, Wijns W, Kolanowski J, Bol A, Decoster PM, Michel C, Cogneau M, Heyndrickx GR, Essamri B, Melin JA. Competition between palmitate and ketone bodies as fuels for the heart: study with positron emission tomography. Am J Physiol Heart Circ Physiol 264: H701-H707, 1993.
219. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70: 309-319, 2004.
220. Vila-Brau A, Sousa-Coelho ALD, Mayordomo C, Haro D, Marrero PF. Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line. J Biol Chem 286: 20423-20430, 2011.
221. Wang P, Tate JM, Lloyd SG. Low carbohydrate diet decreases myocardial insulin signaling and increases susceptibility to myocardial ischemia. Life Sci 83: 836-844, 2008.
222. Wang X, Levi AJ, Halestrap AP. Substrate and inhibitor specificities of the monocarboxylate transporters of single rat heart cells. Am J Physiol Heart Circ Physiol 270: H476-H484, 1996.
223. Wang Y, Peng F, Tong W, Sun H, Xu N, Liu S. The nitrated proteome in heart mitochondria of the db/db mouse model: Characterization of nitrated tyrosine residues in SCOT. J Proteome Res 9: 4254-4263, 2010.
224. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472: 57-63, 2011.
225. Ward Platt M, Deshpande S. Metabolic adaptation at birth. Semin Fetal Neonatal Med 10: 341-350, 2005.
226. +)-3-hydroxybutyrate, D(-)-3-hydroxybutyrate, acetoacetate, and glucose for respiration and lipid synthesis in the 18-day-old rat. J Biol Chem 252: 5222-5226, 1977.
227. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113, 2008.
228. Wentz AE, d'Avignon DA, Weber ML, Cotter DG, Doherty JM, Kerns R, Nagarajan R, Sambandam N, Crawford PA. Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment. J Biol Chem 285: 24447-24456, 2010.
229. Williamson DH, Bates MW, Page MA, Krebs HA. Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues. Biochem J 121: 41-47, 1971.
230. Williamson DH, Lund P, Krebs HA. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 103: 514-527, 1967.
231. Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432: 1027-1032, 2004.
232. Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X, Yu P, Zhao C, Li L, Zhou A, Wang J, Moore JE, Millar BC, Xu J. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 61: 69-78, 2010.
233. Yamasaki M, Hasegawa S, Suzuki H, Hidai K, Saitoh Y, Fukui T. Acetoacetyl-CoA synthetase gene is abundant in rat adipose, and related with fatty acid synthesis in mature adipocytes. Biochem Biophys Res Commun 335: 215-219, 2005.
234. Yan J, Young ME, Cui L, Lopaschuk GD, Liao R, Tian R. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 119: 2818-2828, 2009.
235. Yang SY, He XY, Schulz H. Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-coenzyme a thiolase. J Biol Chem 262: 13027-11303, 1987.
236. Yang X, Cheng B. Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. J Mol Neurosci 42: 145-153, 2010.
237. Yao J, Chen S, Mao Z, Cadenas E, Brinton R. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease. PLoS One 6: e21788, 2011.
238. Yoo H, Stephanopoulos G, Kelleher JK. Quantifying carbon sources for de novo lipogenesis in wild-type and IRS-1 knockout brown adipocytes. J Lipid Res 45: 1324-1332, 2004.
239. Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 105: 1861-1870, 2002.
240. Zammit VA, Beis A, Newsholme EA. The role of 3-oxo acid-CoA transferase in the regulation of ketogenesis in the liver. FEBS Lett 103: 212-215, 1979.
241. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE, Krajmalnik-Brown R. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 106: 2365-2370, 2009.
242. Zhang WW, Churchill S, Churchill P. Developmental regulation of D-β-hydroxybutyrate dehydrogenase in rat liver and brain. FEBS Lett 256: 71-74, 1989.
243. Zhang Z, Tan M, Xie Z, Dai L, Chen Y, Zhao Y. Identification of lysine succinylation as a new post-translational modification. Nat Chem Biol 2011: 58-63, 2010.
244. Zou Z, Sasaguri S, Rajesh KG, Suzuki R. dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts. Am J Physiol Heart Circ Physiol 283: H1968-H1974, 2002.